Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tafolecimab: First Approval
Susan J. Keam
Drugs (2023) Vol. 83, Iss. 16, pp. 1545-1549
Closed Access | Times Cited: 10

Showing 10 citing articles:

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Xuhui Bao, Yongjun Liang, Hanman Chang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
The Hurdle of Access to Emerging Therapies and Potential Solutions in the Management of Dyslipidemias
Brett S. Mansfield, Farzahna Mohamed, Miriam Larouche, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4160-4160
Open Access | Times Cited: 6
Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives
Pratiksha Jamadade, Neh Nupur, Krushna Ch Maharana, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 10, pp. 549-571
Closed Access | Times Cited: 5
Inhibition of PCSK9: a promising enhancer for anti-PD-1/PD-L1 immunotherapy
Shengbo Sun, Jingxin Ma, Tingting Zuo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 5
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?
Alberto Corsini, Henry N. Ginsberg, M. John Chapman
Pharmacology & Therapeutics (2025), pp. 108812-108812
Closed Access
Emerging roles of PCSK9 in kidney disease: lipid metabolism, megalin regulation and proteinuria
Sandra Hummelgaard, Jean‐Claude Kresse, Michael Schou Jensen, et al.
Pflügers Archiv - European Journal of Physiology (2025)
Closed Access
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling
Chengsha Yuan, Changpeng� Hu, Huyue Zhou, et al.
Neoplasia (2025) Vol. 64, pp. 101160-101160
Closed Access
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
Huihui Liu, Sha Li, Jian‐Jun Li
Drugs (2025)
Closed Access
An up-to-date review of emerging biologic therapies for hypercholesterolemia
Brian Tomlinson
Expert Opinion on Biological Therapy (2024)
Closed Access | Times Cited: 1
The associations between dietary flavonoid intake and hyperlipidemia: data from the national health and nutrition examination survey 2007–2010 and 2017–2018
Yingying Wan, Dan Ma, Linghua Yu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Page 1

Scroll to top